The study performed by Zhang Y et al. found that, in the case of GC, tumour growth and angiogenesis were inhibited by the injection of PEDF via the downregulation of both hypoxia-inducible factor 1 alpha (HIF-1 α) and vascular endothelial growth factor (VEGF) [80]. The gene discussed is VEGFA; the disease is gastric cancer.